Hopkinson Craig C. (CIK 0001730048)

Latest company ownership

ALKS - Alkermes plc.
Role: EVP R&D, Chief Medical Officer
Shares held
109,592
Last filed at
Dec 5, 2025
Confidence Score
11.8
2025Q4
Confidence Score History
2018Q2 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Dec 3, 2025 Dec 5, 2025 Alkermes plc. EVP R&D, Chief Medical Officer Sell 32.5 -3,748 -5.39% ✓ $112.4K
Dec 1, 2025 Dec 1, 2025 Alkermes plc. EVP R&D, Chief Medical Officer Sell 32.5 -4,000 -5.74% ✓ $117.2K
Nov 3, 2025 Nov 3, 2025 Alkermes plc. EVP R&D, Chief Medical Officer Sell 22.5 -9,000 -11.43% ✓ $273.4K
Oct 15, 2025 Oct 15, 2025 Alkermes plc. EVP R&D, Chief Medical Officer Sell 22.5 -9,000 -10.88% ✓ $283.8K
Feb 26, 2025 Feb 28, 2025 Alkermes plc. EVP R&D, Chief Medical Officer Sell 22.5 -3,049 -3.77% ✗ $106.1K
Feb 22, 2025 Feb 25, 2025 Alkermes plc. EVP R&D, Chief Medical Officer Sell 20.0 -8,866 -5.82% ✗ $313.1K
Feb 18, 2025 Feb 20, 2025 Alkermes plc. EVP R&D, Chief Medical Officer Sell 22.5 -3,950 -5.92% ✗ $141.8K
Feb 12, 2025 Feb 14, 2025 Alkermes plc. EVP R&D, Chief Medical Officer Sell 2.5 -349,340 -48.33% ✓ $11.8M
Feb 6, 2025 Feb 7, 2025 Alkermes plc. EVP R&D, Chief Medical Officer Sell 97.5 +19,310 43.60% ✗ $473.5K
Jan 30, 2025 Jan 31, 2025 Alkermes plc. EVP R&D, Chief Medical Officer Sell 5.0 -100,918 -69.50% ✓ $3.2M
Dec 9, 2024 Dec 9, 2024 Alkermes plc. EVP R&D, Chief Medical Officer Sell 5.0 -61,151 -56.24% ✓ $2M
Dec 5, 2024 Dec 5, 2024 Alkermes plc. EVP R&D, Chief Medical Officer Sell 22.5 -9,221 -13.37% ✓ $290.5K
Dec 4, 2024 Dec 4, 2024 Alkermes plc. EVP R&D, Chief Medical Officer Sell 17.5 -14,349 -17.23% ✓ $441.6K
Nov 11, 2024 Nov 12, 2024 Alkermes plc. EVP R&D, Chief Medical Officer Sell 5.0 -58,996 -41.46% ✓ $1.8M
Nov 6, 2024 Nov 6, 2024 Alkermes plc. EVP R&D, Chief Medical Officer Sell 26.3 -10,471 -9.54% ✓ $309.2K
Feb 23, 2024 Feb 27, 2024 Alkermes plc. EVP R&D, Chief Medical Officer Sell 22.5 -3,414 -3.02% ✗ $101K
Feb 22, 2024 Feb 23, 2024 Alkermes plc. EVP R&D, Chief Medical Officer Sell 22.5 -5,452 -4.92% ✗ $157.6K
Feb 18, 2024 Feb 21, 2024 Alkermes plc. EVP R&D, Chief Medical Officer Sell 20.0 -8,523 -4.26% ✗ $266.1K
Feb 8, 2024 Feb 12, 2024 Alkermes plc. EVP R&D, Chief Medical Officer Sell 97.5 +31,378 55.48% ✗ $409K
Feb 22, 2023 Feb 24, 2023 Alkermes plc. EVP R&D, Chief Medical Officer Sell 22.5 -5,345 -8.63% ✗ $148.4K
Feb 18, 2023 Feb 22, 2023 Alkermes plc. EVP R&D, Chief Medical Officer Sell 90.0 +6,180 3.14% ✗ $448.6K
Feb 23, 2022 Feb 24, 2022 Alkermes plc. EVP R&D, Chief Medical Officer Sell 7.5 -11,983 -39.97% ✓ $296.7K
Feb 18, 2022 Feb 23, 2022 Alkermes plc. EVP R&D, Chief Medical Officer Sell 22.5 -10,833 -12.25% ✓ $271.7K
Feb 16, 2022 Feb 17, 2022 Alkermes plc. EVP R&D, Chief Medical Officer Sell 26.3 -1,069 -8.31% ✗ $28.6K
Sep 14, 2021 Sep 16, 2021 Alkermes plc. EVP R&D, Chief Medical Officer Sell 95.0 +9,496 100.00% ✗ $172.8K
Jun 9, 2021 Jun 11, 2021 Alkermes plc. EVP R&D, Chief Medical Officer Sell 13.8 -882 -100.00% ✓ $21.7K
Jun 7, 2021 Jun 8, 2021 Alkermes plc. EVP R&D, Chief Medical Officer Sell 27.5 -368 -29.44% ✗ $8.6K
Apr 15, 2021 Apr 16, 2021 Alkermes plc. EVP R&D, Chief Medical Officer Sell 7.5 -28,920 -100.00% ✓ $570.3K
Feb 20, 2021 Feb 23, 2021 Alkermes plc. EVP R&D, Chief Medical Officer Sell 22.5 -5,086 -8.76% ✗ $99.6K
Feb 16, 2021 Feb 18, 2021 Alkermes plc. EVP R&D, Chief Medical Officer Sell 26.3 -1,172 -6.44% ✗ $23.2K
Jun 7, 2020 Jun 8, 2020 Alkermes plc. EVP R&D, Chief Medical Officer Sell 27.5 -368 -2.42% ✗ $6.3K
Feb 21, 2020 Feb 24, 2020 Alkermes plc. EVP R&D, Chief Medical Officer Sell 26.3 -2,004 -12.56% ✗ $40.6K
Feb 16, 2020 Feb 18, 2020 Alkermes plc. EVP R&D, Chief Medical Officer Sell 26.3 -1,172 -11.43% ✗ $20.8K
Jun 7, 2019 Jun 10, 2019 Alkermes plc. SVP, Med Dev/Med Affairs, CMO Sell 27.5 -368 -5.08% ✗ $8.4K
Feb 16, 2019 Feb 19, 2019 Alkermes plc. SVP, Med Dev/Med Affairs, CMO Sell 26.3 -1,083 -15.30% ✗ $35.2K
Dec 7, 2018 Dec 11, 2018 Alkermes plc. SVP, Med Dev/Med Affairs, CMO Sell 91.3 +2,822 320.32% ✗ $40.1K
Jun 7, 2018 Jun 8, 2018 Alkermes plc. SVP, Med Dev/Med Affairs, CMO Sell 26.3 -369 -29.52% ✗ $17.8K